DESCRIPTION
Frequent description
The commercial exploitation of plant cell, tissue and organ cultures is now a actuality and the model new utilized sciences are already in place and creating shortly. Their emergence has provided new views and sharpened the principle focus of the strategies by which plant cell and tissue custom can help man. Together with the thrilling new developments in plant molecular biology, these in vitro procedures must allow plant bio technologists to ‘design’ crops and plant merchandise and exploit the whole industrial potential of plant cell cultures.
PROPERTIES
Top quality Stage
200
natural provide
algae (Rhodophyceae)
sort
powder
utility(s)
cell custom | mammalian: acceptable
cell custom | plant: acceptable
microbiology: acceptable
transition temp
congealing temperature <38 °C (1.5% in H2O)
suitability
microbiology examined
Featured Enterprise
Agriculture
storage temp.
room temp
Utility
Agar has been used:
- as a reference commonplace industrial agar to match the physio-chemical, gelling properties of alkali-treated agar from Gracilaria tenuistipitata
- as an element inside the seed germination medium and rooting medium for commercially obtainable soybean (Glycine max (L.) Merr) seeds
- as part of improvement media for B. subtilis mutant strain MTC871 based biofilm colonies
- as a bacteriological agar half to rearrange half energy Murashige-Skoog (MS 50%) medium for Echinocactus platycanthus seeds custom
PPM
Typical working focus: 6-12g/L.
Packaging
Biochem/physiol Actions
Completely different Notes
Bacterial Illnesses
Some micro organism inflicting infecting Cannabis crops embrace Pseudomonas syringae and Xanthomonas campestris pv. Cannabis. The indicators of Pseudomonas syringae are small water-soaked leaf spots which is able to enlarge alongside the veins, turning brown. The Xanthomonas campestris causes leaf spots and wilting in crops.
Fungal Illnesses
Just a few of the principle cannabis infecting fungus and illnesses attributable to them are:
- Fusarium oxysporum f.sp. Cannabis causes wilt whose indicators embrace yellowing of leaves, poor improvement, and wilt.
- Pythium sickness causes root rot and damping-off sickness whose indicators fluctuate from small roots lesions, excessive root damage, stunted improvement, to yellowing of leaves. Extra, damping-off impacts youthful seedlings.
- Sclerotinia sclerotiorum causes hemp canker whose preliminary indicators embrace watersoaked lesions on stalks and branches that will later set off cankers. Typically cottony white mycelium and black sclerotia could appear.
- Sphaeorotheca macularis or Leveillula taurica causes powdery mildew. It’s one of many essential widespread foliar illnesses of cannabis. Its indicators embrace powdery improvement on the ground of leaves that later turns brown.
- The cannabis plant will be affected by Alternaria species, which causes leaf spot and brown blight illnesses.
Viral and Viroid Illnesses
Viruses affecting cannabis embrace Hop mosaic virus (HpMV), Apple mosaic virus (ApMV), Hop stunt viroid (HSVd), Hop latent viroid, Arabis mosaic virus (ArMV), Alfalfa mosaic virus (AMV), Tobacco mosaic virus (TMC), Cucumber mosaic virus (CMV), and phytoplasmas.
The viruses could trigger excessive crop losses, reduce improvement, or impact the yield and prime quality of crops. The widespread indicators of viruses embrace yellow and inexperienced mosaic patterns on the leaves of Cannabis and curling, distortion, and narrowing of youthful leaves. Phytoplasmas primarily set off excessive shoot proliferation and stunted improvement.
 Anti-Hu CD273 PE |
|||
| 1P-178-T025 | ExBio | 25 tests | EUR 168 |
Anti-Hu CD273 PE |
|||
| 1P-178-T100 | ExBio | 100 tests | EUR 288 |
 Anti-Hu CD273 APC |
|||
| 1A-178-T100 | ExBio | 100 tests | EUR 288 |
 Anti-Hu CD273 Purified |
|||
| 11-178-C025 | ExBio | 0.025 mg | EUR 118.8 |
Anti-Hu CD273 Purified |
|||
| 11-178-C100 | ExBio | 0.1 mg | EUR 189.6 |
 mAb) Mouse Anti-Human CD273 (PD-L2) mAb |
|||
| CM031-100ug | SAB | 100ug | EUR 250.8 |
Mouse Anti-Human CD273 (PD-L2) mAb |
|||
| CM031-25ug | SAB | 25ug | EUR 154.8 |
 Anti-Hu CD273 Alexa Fluor647 |
|||
| A6-178-T100 | ExBio | 100 tests | EUR 322.8 |
 CD273 [PD-L2] Recombinant Protein |
|||
| 90-425 | ProSci | 100 ug | EUR 651.3 |
|
Description: T cells require a signal induced by the engagement of the T cell receptor and a costimulatory signal(s) through distinct T cell surface molecules for optimal T cell activation and tolerance. CD273 (PD-L2) is one of two ligands for programmed death-1 (PD-1; CD279), a member of the CD28 family of immunoreceptors. The other identified ligand is PD-L1. CD273 is broadly expressed and also up regulated in a variety of tumor cell lines. On previously activated T cells, CD273 interaction with PD-1 inhibits TCR mediated proliferation and cytokine production, suggesting an inhibitory role in regulating immune responses. CD273 has a costimulatory function on resting T cells activated with suboptimal TCR signals. |
|||
CD273 [PD-L2] Recombinant Protein |
|||
| 90-427 | ProSci | 100 ug | EUR 651.3 |
|
Description: T cells require a signal induced by the engagement of the T cell receptor and a costimulatory signal(s) through distinct T cell surface molecules for optimal T cell activation and tolerance. CD273 (PD-L2) is one of two ligands for programmed death-1 (PD-1; CD279), a member of the CD28 family of immunoreceptors. The other identified ligand is PD-L1. CD273 is broadly expressed and also up regulated in a variety of tumor cell lines. On previously activated T cells, CD273 interaction with PD-1 inhibits TCR mediated proliferation and cytokine production, suggesting an inhibitory role in regulating immune responses. CD273 has a costimulatory function on resting T cells activated with suboptimal TCR signals. |
|||
CD273 [PD-L2] Recombinant Protein |
|||
| 90-428 | ProSci | 100 ug | EUR 651.3 |
|
Description: T cells require a signal induced by the engagement of the T cell receptor and a costimulatory signal(s) through distinct T cell surface molecules for optimal T cell activation and tolerance. CD273 (PD-L2) is one of two ligands for programmed death-1 (PD-1; CD279), a member of the CD28 family of immunoreceptors. The other identified ligand is PD-L1. CD273 is broadly expressed and also up regulated in a variety of tumor cell lines. On previously activated T cells, CD273 interaction with PD-1 inhibits TCR mediated proliferation and cytokine production, suggesting an inhibitory role in regulating immune responses. CD273 has a costimulatory function on resting T cells activated with suboptimal TCR signals. |
|||
 Anti-Hu CD273 PE-Cy7 |
|||
| T7-178-T100 | ExBio | 100 tests | EUR 321.6 |
 Recombinant Mouse PD-L2/B7-DC/CD273 Protein |
|||
| RP00660 | Abclonal | 10 μg | EUR 174 |
, Fc fusion (Human)) PD-L2 (CD273), Fc fusion (Human) |
|||
| 71107 | BPS Bioscience | 100 µg | EUR 330 |
|
Description: Human secreted Programmed Death Ligand 2 (PD-L2)-Fc fusion protein, also known as CD273, PDCDL1G2, and B7-DC, GenBank Accession No. NM_025239, a.a. 20-219, fused at the C-terminus to the Fc portion of human IgG1 expressed in a HEK293 cell expression system. MW = 49 kDa. |
|||
 Antibody) Programmed Cell Death 1 Ligand 2 (CD273) Antibody |
|||
| abx140405-01mg | Abbexa | 0.1 mg | EUR 427.2 |
Programmed Cell Death 1 Ligand 2 (CD273) Antibody |
|||
| abx414420-02mg | Abbexa | 0.2 mg | EUR 678 |
Programmed Cell Death 1 Ligand 2 (CD273) Antibody |
|||
| abx414421-01mg | Abbexa | 0.1 mg | EUR 526.8 |
Programmed Cell Death 1 Ligand 2 (CD273) Antibody |
|||
| abx412031-01mg | Abbexa | 0.1 mg | EUR 610.8 |
Programmed Cell Death 1 Ligand 2 (CD273) Antibody |
|||
| abx414235-025mg | Abbexa | 0.25 mg | EUR 678 |
 Anti-CD273/ PD-L2 Antibody [TY25], Unconjugated-100ug |
|||
| QAB101-100ug | EnQuireBio | 100ug | EUR 270 |
 PD-L2 Antibody / Programmed death ligand 2 / CD273 |
|||
| R32447 | NSJ Bioreagents | 100 ug | EUR 419 |
PD-L2 Antibody / Programmed death ligand 2 / CD273 |
|||
| V8176-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: Recognizes a protein of about 31kDa, which is identified as PD-L2 (same as PDCD1LG2). Engagement of CD28 by B7-1 (CD80) or B7-2 (CD86) in the presence of antigen promotes T cell proliferation, cytokine production, differentiation of effector T cells and the induction of Bcl-x, a promoter of T cell survival. Conversely, engagement of CTLA4 by B7-1 or B7-2 may inhibit proliferation and IL-2 production. PD-L2 does not bind CD28, cytotoxic T lymphocyte A4 or ICOS (inducible co-stimulator). The constitutive expression of PD-L1 and PD-L2 on parenchymal cells of heart, lung and kidney suggests that the Pdcd-1-Pdcd-L system could provide unique negative signaling to help prevent autoimmune disease. |
|||
